{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:54:24Z","timestamp":1790016864066,"version":"4.0.1"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","award":["TTU05.816"],"award-info":[{"award-number":["TTU05.816"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB841"],"award-info":[{"award-number":["SFB841"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Semin Immunopathol"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The human hepatitis B virus (HBV) is a small-enveloped DNA virus causing acute and chronic hepatitis. Despite the existence of an effective prophylactic vaccine and the strong capacity of approved antiviral drugs to suppress viral replication, chronic HBV infection (CHB) continues to be a major health burden worldwide. Both the inability of the immune system to resolve CHB and the unique replication strategy employed by HBV, which forms a stable viral covalently closed circular DNA (cccDNA) minichromosome in the hepatocyte nucleus, enable infection persistence. Knowledge of the complex network of interactions that HBV engages with its host is still limited but accumulating evidence indicates that epigenetic modifications occurring both on the cccDNA and on the host genome in the course of infection are essential to modulate viral activity and likely contribute to pathogenesis and cancer development. Thus, a deeper understanding of epigenetic regulatory processes may open new venues to control and eventually cure CHB. This review summarizes major findings in HBV epigenetic research, focusing on the epigenetic mechanisms regulating cccDNA activity and the modifications determined in infected host cells and tumor liver tissues.<\/jats:p>","DOI":"10.1007\/s00281-020-00780-6","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T13:02:47Z","timestamp":1584450167000},"page":"173-185","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Epigenetic modulation in chronic hepatitis B virus infection"],"prefix":"10.1007","volume":"42","author":[{"given":"Maura","family":"Dandri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"key":"780_CR1","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1136\/gutjnl-2014-308943","volume":"64","author":"MB Zeisel","year":"2015","unstructured":"Zeisel MB, Lucifora J, Mason WS, Sureau C, Beck J, Levrero M, Kann M, Knolle PA, Benkirane M, Durantel D, Michel ML, Autran B, Cosset FL, Strick-Marchand H, Tr\u00e9po C, Kao JH, Carrat F, Lacombe K, Schinazi RF, Barr\u00e9-Sinoussi F, Delfraissy JF, Zoulim F (2015) Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure. Gut 64:1314\u20131326. https:\/\/doi.org\/10.1136\/gutjnl-2014-308943","journal-title":"Gut"},{"key":"780_CR2","doi-asserted-by":"publisher","unstructured":"Cornberg M, Suk-Fong Lok A, Terrault NA, Zoulim F, Faculty, E.-A. H. T. E. C (2019) Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV treatment endpoints conference. J Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2019.11.003","DOI":"10.1016\/j.jhep.2019.11.003"},{"key":"780_CR3","doi-asserted-by":"publisher","first-page":"9913","DOI":"10.1073\/pnas.0504273102","volume":"102","author":"SF Wieland","year":"2005","unstructured":"Wieland SF, Eustaquio A, Whitten-Bauer C, Boyd B, Chisari FV (2005) Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids. Proc Natl Acad Sci U S A 102:9913\u20139917. https:\/\/doi.org\/10.1073\/pnas.0504273102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"780_CR4","doi-asserted-by":"publisher","first-page":"9332","DOI":"10.1128\/JVI.00918-10","volume":"84","author":"C Xu","year":"2010","unstructured":"Xu C, Guo H, Pan XB, Mao R, Yu W, Xu X, Wei L, Chang J, Block TM, Guo JT (2010) Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus. J Virol 84:9332\u20139340","journal-title":"J Virol"},{"key":"780_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1172\/JCI58847","volume":"122","author":"L Belloni","year":"2012","unstructured":"Belloni L, Allweiss L, Guerrieri F, Pediconi N, Volz T, Pollicino T, Petersen J, Raimondo G, Dandri M, Levrero M (2012) IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. J Clin Invest 122:529\u2013537. https:\/\/doi.org\/10.1172\/JCI58847","journal-title":"J Clin Invest"},{"issue":"Suppl 4","key":"780_CR6","doi-asserted-by":"publisher","first-page":"S281","DOI":"10.1093\/cid\/ciw023","volume":"62","author":"M Dandri","year":"2016","unstructured":"Dandri M, Petersen J (2016) Mechanism of hepatitis B virus persistence in hepatocytes and its carcinogenic potential. Clin Infect Dis 62(Suppl 4):S281\u2013S288. https:\/\/doi.org\/10.1093\/cid\/ciw023","journal-title":"Clin Infect Dis"},{"key":"780_CR7","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S2468-1253(19)30119-0","volume":"4","author":"PA Revill","year":"2019","unstructured":"Revill PA, Chisari FV, Block JM, Dandri M, Gehring AJ, Guo H, Hu J, Kramvis A, Lampertico P, Janssen HLA, Levrero M, Li W, Liang TJ, Lim SG, Lu F, Penicaud MC, Tavis JE, Thimme R, Members of the ICE-HBV Working Groups., ICE-HBV Stakeholders Group Chairs., ICE-HBV Senior Advisors, Zoulim F (2019) A global scientific strategy to cure hepatitis B. Lancet Gastroenterol Hepatol 4:545\u2013558. https:\/\/doi.org\/10.1016\/S2468-1253(19)30119-0","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"780_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/liv.13656","volume":"38","author":"RF Schinazi","year":"2018","unstructured":"Schinazi RF, Ehteshami M, Bassit L, Asselah T (2018) Towards HBV curative therapies. Liver Int 38(Suppl 1):102\u2013114. https:\/\/doi.org\/10.1111\/liv.13656","journal-title":"Liver Int"},{"key":"780_CR9","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1002\/hep.29479","volume":"66","author":"X Hong","year":"2017","unstructured":"Hong X, Kim ES, Guo H (2017) Epigenetic regulation of hepatitis B virus covalently closed circular DNA: implications for epigenetic therapy against chronic hepatitis B. Hepatology 66:2066\u20132077. https:\/\/doi.org\/10.1002\/hep.29479","journal-title":"Hepatology"},{"key":"780_CR10","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1038\/s41467-018-06739-4","volume":"9","author":"P Moreau","year":"2018","unstructured":"Moreau P, Cournac A, Palumbo GA, Marbouty M, Mortaza S, Thierry A, Cairo S, Lavigne M, Koszul R, Neuveut C (2018) Tridimensional infiltration of DNA viruses into the host genome shows preferential contact with active chromatin. Nat Commun 9:4268. https:\/\/doi.org\/10.1038\/s41467-018-06739-4","journal-title":"Nat Commun"},{"key":"780_CR11","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","volume":"64","author":"M Nassal","year":"2015","unstructured":"Nassal M (2015) HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B. Gut 64:1972\u20131984. https:\/\/doi.org\/10.1136\/gutjnl-2015-309809","journal-title":"Gut"},{"key":"780_CR12","doi-asserted-by":"publisher","unstructured":"Allweiss L, Dandri M (2017) The role of cccDNA in HBV maintenance. Viruses 9. https:\/\/doi.org\/10.3390\/v9060156","DOI":"10.3390\/v9060156"},{"key":"780_CR13","doi-asserted-by":"publisher","unstructured":"Yan H et al (2012) Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 3. https:\/\/doi.org\/10.7554\/eLife.00049","DOI":"10.7554\/eLife.00049"},{"key":"780_CR14","doi-asserted-by":"publisher","unstructured":"Gallucci L, Kann M (2017) Nuclear import of hepatitis B virus capsids and genome. Viruses 9. https:\/\/doi.org\/10.3390\/v9010021","DOI":"10.3390\/v9010021"},{"key":"780_CR15","doi-asserted-by":"publisher","first-page":"e43270","DOI":"10.1371\/journal.pone.0043270","volume":"7","author":"H Guo","year":"2012","unstructured":"Guo H, Xu C, Zhou T, Block TM, Guo JT (2012) Characterization of the host factors required for hepadnavirus covalently closed circular (ccc) DNA formation. PLoS One 7:e43270. https:\/\/doi.org\/10.1371\/journal.pone.0043270","journal-title":"PLoS One"},{"key":"780_CR16","doi-asserted-by":"publisher","unstructured":"Schreiner S, Nassal M (2017) A role for the host DNA damage response in hepatitis B virus cccDNA formation-and beyond? Viruses 9. https:\/\/doi.org\/10.3390\/v9050125","DOI":"10.3390\/v9050125"},{"key":"780_CR17","doi-asserted-by":"publisher","first-page":"12472","DOI":"10.1128\/JVI.01123-07","volume":"81","author":"H Guo","year":"2007","unstructured":"Guo H et al (2007) Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation. J Virol 81:12472\u201312484. https:\/\/doi.org\/10.1128\/JVI.01123-07","journal-title":"J Virol"},{"key":"780_CR18","doi-asserted-by":"publisher","first-page":"E4244","DOI":"10.1073\/pnas.1409986111","volume":"111","author":"C Koniger","year":"2014","unstructured":"Koniger C et al (2014) Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses. Proc Natl Acad Sci U S A 111:E4244\u2013E4253. https:\/\/doi.org\/10.1073\/pnas.1409986111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"780_CR19","doi-asserted-by":"publisher","first-page":"e1005893","DOI":"10.1371\/journal.ppat.1005893","volume":"12","author":"Y Qi","year":"2016","unstructured":"Qi Y, Gao Z, Xu G, Peng B, Liu C, Yan H, Yao Q, Sun G, Liu Y, Tang D, Song Z, He W, Sun Y, Guo JT, Li W (2016) DNA polymerase kappa is a key cellular factor for the formation of covalently closed circular DNA of hepatitis B virus. PLoS Pathog 12:e1005893. https:\/\/doi.org\/10.1371\/journal.ppat.1005893","journal-title":"PLoS Pathog"},{"key":"780_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1006\/jmbi.2000.4481","volume":"307","author":"CT Bock","year":"2001","unstructured":"Bock CT, Schwinn S, Locarnini S, Fyfe J, Manns MP, Trautwein C, Zentgraf H (2001) Structural organization of the hepatitis B virus minichromosome. J Mol Biol 307:183\u2013196. https:\/\/doi.org\/10.1006\/jmbi.2000.4481","journal-title":"J Mol Biol"},{"key":"780_CR21","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jhep.2009.05.022","volume":"51","author":"M Levrero","year":"2009","unstructured":"Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G, Dandri M (2009) Control of cccDNA function in hepatitis B virus infection. J Hepatol 51:581\u2013592. https:\/\/doi.org\/10.1016\/j.jhep.2009.05.022","journal-title":"J Hepatol"},{"key":"780_CR22","doi-asserted-by":"publisher","first-page":"E5715","DOI":"10.1073\/pnas.1518090112","volume":"112","author":"P Tropberger","year":"2015","unstructured":"Tropberger P, Mercier A, Robinson M, Zhong W, Ganem DE, Holdorf M (2015) Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation. Proc Natl Acad Sci U S A 112:E5715\u2013E5724. https:\/\/doi.org\/10.1073\/pnas.1518090112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"780_CR23","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jhep.2013.06.020","volume":"59","author":"J Hoffmann","year":"2013","unstructured":"Hoffmann J, Boehm C, Himmelsbach K, Donnerhak C, Roettger H, Weiss TS, Ploen D, Hildt E (2013) Identification of alpha-taxilin as an essential factor for the life cycle of hepatitis B virus. J Hepatol 59:934\u2013941. https:\/\/doi.org\/10.1016\/j.jhep.2013.06.020","journal-title":"J Hepatol"},{"key":"780_CR24","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/hep.25592","volume":"56","author":"T Pollicino","year":"2012","unstructured":"Pollicino T, Amaddeo G, Restuccia A, Raffa G, Alibrandi A, Cutroneo G, Favaloro A, Maimone S, Squadrito G, Raimondo G (2012) Impact of hepatitis B virus (HBV) preS\/S genomic variability on HBV surface antigen and HBV DNA serum levels. Hepatology 56:434\u2013443. https:\/\/doi.org\/10.1002\/hep.25592","journal-title":"Hepatology"},{"key":"780_CR25","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1053\/j.gastro.2007.06.057","volume":"133","author":"T Volz","year":"2007","unstructured":"Volz T, Lutgehetmann M, Wachtler P, Jacob A, Quaas A, Murray JM, Dandri M, Petersen J (2007) Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients. Gastroenterology 133:843\u2013852. https:\/\/doi.org\/10.1053\/j.gastro.2007.06.057","journal-title":"Gastroenterology"},{"key":"780_CR26","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/hep.21299","volume":"44","author":"A Laras","year":"2006","unstructured":"Laras A, Koskinas J, Dimou E, Kostamena A, Hadziyannis SJ (2006) Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients. Hepatology 44:694\u2013702","journal-title":"Hepatology"},{"key":"780_CR27","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1053\/j.gastro.2004.03.018","volume":"126","author":"B Werle-Lapostolle","year":"2004","unstructured":"Werle-Lapostolle B, Bowden S, Locarnini S, Wursthorn K, Petersen J, Lau G, Trepo C, Marcellin P, Goodman Z, Delaney WE 4th, Xiong S, Brosgart CL, Chen SS, Gibbs CS, Zoulim F (2004) Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 126:1750\u20131758","journal-title":"Gastroenterology"},{"key":"780_CR28","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jhep.2013.10.021","volume":"60","author":"L Allweiss","year":"2014","unstructured":"Allweiss L, Volz T, L\u00fctgehetmann M, Giersch K, Bornscheuer T, Lohse AW, Petersen J, Ma H, Klumpp K, Fletcher SP, Dandri M (2014) Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration. J Hepatol 60:500\u2013507. https:\/\/doi.org\/10.1016\/j.jhep.2013.10.021","journal-title":"J Hepatol"},{"key":"780_CR29","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/hep.24758","volume":"55","author":"M Lutgehetmann","year":"2012","unstructured":"Lutgehetmann M et al (2012) Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation. Hepatology 55:685\u2013694. https:\/\/doi.org\/10.1002\/hep.24758","journal-title":"Hepatology"},{"key":"780_CR30","doi-asserted-by":"publisher","unstructured":"Balagopal A et al (2019) Single hepatocyte hepatitis B virus transcriptional landscape in HIV co-infection. J Infect Dis. https:\/\/doi.org\/10.1093\/infdis\/jiz607","DOI":"10.1093\/infdis\/jiz607"},{"key":"780_CR31","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jmoldx.2018.01.010","volume":"20","author":"JT Huang","year":"2018","unstructured":"Huang JT, Yang Y, Hu YM, Liu XH, Liao MY, Morgan R, Yuan EF, Li X, Liu SM (2018) A highly sensitive and robust method for hepatitis B virus covalently closed circular DNA detection in single cells and serum. J Mol Diagn 20:334\u2013343. https:\/\/doi.org\/10.1016\/j.jmoldx.2018.01.010","journal-title":"J Mol Diagn"},{"key":"780_CR32","doi-asserted-by":"publisher","first-page":"e1001082","DOI":"10.1371\/journal.ppat.1001082","volume":"6","author":"J Kock","year":"2010","unstructured":"Kock J et al (2010) Generation of covalently closed circular DNA of hepatitis B viruses via intracellular recycling is regulated in a virus specific manner. PLoS Pathog 6:e1001082. https:\/\/doi.org\/10.1371\/journal.ppat.1001082","journal-title":"PLoS Pathog"},{"key":"780_CR33","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1172\/JCI120228","volume":"129","author":"K Wisskirchen","year":"2019","unstructured":"Wisskirchen K, Kah J, Malo A, Asen T, Volz T, Allweiss L, Wettengel JM, L\u00fctgehetmann M, Urban S, Bauer T, Dandri M, Protzer U (2019) T cell receptor grafting allows virological control of hepatitis B virus infection. J Clin Invest 129:2932\u20132945. https:\/\/doi.org\/10.1172\/JCI120228","journal-title":"J Clin Invest"},{"key":"780_CR34","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1126\/science.1243462","volume":"343","author":"J Lucifora","year":"2014","unstructured":"Lucifora J, Xia Y, Reisinger F, Zhang K, Stadler D, Cheng X, Sprinzl MF, Koppensteiner H, Makowska Z, Volz T, Remouchamps C, Chou WM, Thasler WE, H\u00fcser N, Durantel D, Liang TJ, M\u00fcnk C, Heim MH, Browning JL, Dejardin E, Dandri M, Schindler M, Heikenwalder M, Protzer U (2014) Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science 343:1221\u20131228. https:\/\/doi.org\/10.1126\/science.1243462","journal-title":"Science"},{"issue":"Suppl 1","key":"780_CR35","doi-asserted-by":"publisher","first-page":"i6","DOI":"10.1136\/gutjnl-2012-302056","volume":"61","author":"M Dandri","year":"2012","unstructured":"Dandri M, Locarnini S (2012) New insight in the pathobiology of hepatitis B virus infection. Gut 61(Suppl 1):i6\u2013i17. https:\/\/doi.org\/10.1136\/gutjnl-2012-302056","journal-title":"Gut"},{"key":"780_CR36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1146\/annurev.immunol.19.1.65","volume":"19","author":"LG Guidotti","year":"2001","unstructured":"Guidotti LG, Chisari FV (2001) Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 19:65\u201391","journal-title":"Annu Rev Immunol"},{"key":"780_CR37","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1136\/gutjnl-2011-301073","volume":"61","author":"A Bertoletti","year":"2012","unstructured":"Bertoletti A, Ferrari C (2012) Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut 61:1754\u20131764. https:\/\/doi.org\/10.1136\/gutjnl-2011-301073","journal-title":"Gut"},{"key":"780_CR38","doi-asserted-by":"publisher","first-page":"6669","DOI":"10.1073\/pnas.0401771101","volume":"101","author":"S Wieland","year":"2004","unstructured":"Wieland S, Thimme R, Purcell RH, Chisari FV (2004) Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A 101:6669\u20136674. https:\/\/doi.org\/10.1073\/pnas.0401771101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"780_CR39","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1053\/j.gastro.2009.06.054","volume":"137","author":"C Dunn","year":"2009","unstructured":"Dunn C, Peppa D, Khanna P, Nebbia G, Jones M, Brendish N, Lascar RM, Brown D, Gilson RJ, Tedder RJ, Dusheiko GM, Jacobs M, Klenerman P, Maini MK (2009) Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 137:1289\u20131300","journal-title":"Gastroenterology"},{"key":"780_CR40","doi-asserted-by":"publisher","unstructured":"Giersch K et al (2015) Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection. J Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2015.03.011","DOI":"10.1016\/j.jhep.2015.03.011"},{"key":"780_CR41","unstructured":"who (2018) Hepatitis B key facts"},{"key":"780_CR42","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1055\/s-0033-1345721","volume":"33","author":"F Guerrieri","year":"2013","unstructured":"Guerrieri F, Belloni L, Pediconi N, Levrero M (2013) Molecular mechanisms of HBV-associated hepatocarcinogenesis. Semin Liver Dis 33:147\u2013156. https:\/\/doi.org\/10.1055\/s-0033-1345721","journal-title":"Semin Liver Dis"},{"key":"780_CR43","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","volume":"64","author":"M Levrero","year":"2016","unstructured":"Levrero M, Zucman-Rossi J (2016) Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol 64:S84\u2013S101. https:\/\/doi.org\/10.1016\/j.jhep.2016.02.021","journal-title":"J Hepatol"},{"key":"780_CR44","doi-asserted-by":"publisher","unstructured":"Kanda T, Goto T, Hirotsu Y, Moriyama M, Omata M (2019) Molecular mechanisms driving progression of liver cirrhosis towards hepatocellular carcinoma in chronic hepatitis B and C infections: a review. Int J Mol Sci 20. https:\/\/doi.org\/10.3390\/ijms20061358","DOI":"10.3390\/ijms20061358"},{"key":"780_CR45","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/gutjnl-2016-312162","volume":"67","author":"L Allweiss","year":"2018","unstructured":"Allweiss L, Volz T, Giersch K, Kah J, Raffa G, Petersen J, Lohse AW, Beninati C, Pollicino T, Urban S, L\u00fctgehetmann M, Dandri M (2018) Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo. Gut 67:542\u2013552. https:\/\/doi.org\/10.1136\/gutjnl-2016-312162","journal-title":"Gut"},{"key":"780_CR46","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1053\/jhep.2002.30203","volume":"35","author":"M Dandri","year":"2002","unstructured":"Dandri M et al (2002) Increase in de novo HBV DNA integrations in response to oxidative DNA damage or inhibition of poly(ADP-ribosyl)ation. Hepatology 35:217\u2013223","journal-title":"Hepatology"},{"key":"780_CR47","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","volume":"479-480","author":"C Seeger","year":"2015","unstructured":"Seeger C, Mason WS (2015) Molecular biology of hepatitis B virus infection. Virology 479-480:672\u2013686. https:\/\/doi.org\/10.1016\/j.virol.2015.02.031","journal-title":"Virology"},{"key":"780_CR48","doi-asserted-by":"publisher","unstructured":"Mason WS et al (2016) HBV DNA integration and clonal hepatocyte expansion in chronic hepatitis B patients considered immune tolerant. Gastroenterology. https:\/\/doi.org\/10.1053\/j.gastro.2016.07.012","DOI":"10.1053\/j.gastro.2016.07.012"},{"key":"780_CR49","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1080\/22221751.2019.1625728","volume":"8","author":"Y Yan","year":"2019","unstructured":"Yan Y, Allweiss L, Yang D, Kang J, Wang J, Qian X, Zhang T, Liu H, Wang L, Liu S, Sui J, Chen X, Dandri M, Zhao J, Lu F (2019) Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection. Emerg Microbes Infect 8:879\u2013894. https:\/\/doi.org\/10.1080\/22221751.2019.1625728","journal-title":"Emerg Microbes Infect"},{"key":"780_CR50","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/hep.29463","volume":"67","author":"B Halgand","year":"2018","unstructured":"Halgand B et al (2018) Hepatitis B virus pregenomic RNA in hepatocellular carcinoma: a nosological and prognostic determinant. Hepatology 67:86\u201396. https:\/\/doi.org\/10.1002\/hep.29463","journal-title":"Hepatology"},{"key":"780_CR51","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1053\/j.gastro.2004.09.016","volume":"127","author":"C Brechot","year":"2004","unstructured":"Brechot C (2004) Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 127:S56\u2013S61","journal-title":"Gastroenterology"},{"key":"780_CR52","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/s0168-8278(03)00217-4","volume":"39","author":"M Iavarone","year":"2003","unstructured":"Iavarone M, Trabut JB, Delpuech O, Carnot F, Colombo M, Kremsdorf D, Br\u00e9chot C, Thiers V (2003) Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissection. J Hepatol 39:253\u2013261. https:\/\/doi.org\/10.1016\/s0168-8278(03)00217-4","journal-title":"J Hepatol"},{"key":"780_CR53","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3748\/wjg.v13.i1.74","volume":"13","author":"J Lupberger","year":"2007","unstructured":"Lupberger J, Hildt E (2007) Hepatitis B virus-induced oncogenesis. World J Gastroenterol 13:74\u201381","journal-title":"World J Gastroenterol"},{"key":"780_CR54","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1128\/JVI.01609-10","volume":"85","author":"T Pollicino","year":"2011","unstructured":"Pollicino T, Raffa G, Santantonio T, Gaeta GB, Iannello G, Alibrandi A, Squadrito G, Cacciola I, Calvi C, Colucci G, Levrero M, Raimondo G (2011) Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. J Virol 85:432\u2013439","journal-title":"J Virol"},{"key":"780_CR55","doi-asserted-by":"publisher","first-page":"104618","DOI":"10.1016\/j.antiviral.2019.104618","volume":"172","author":"L Riviere","year":"2019","unstructured":"Riviere L et al (2019) Hepatitis B virus replicating in hepatocellular carcinoma encodes HBx variants with preserved ability to antagonize restriction by Smc5\/6. Antivir Res 172:104618. https:\/\/doi.org\/10.1016\/j.antiviral.2019.104618","journal-title":"Antivir Res"},{"key":"780_CR56","doi-asserted-by":"publisher","first-page":"5246","DOI":"10.1128\/JVI.70.8.5246-5254.1996","volume":"70","author":"M Dandri","year":"1996","unstructured":"Dandri M, Schirmacher P, Rogler CE (1996) Woodchuck hepatitis virus X protein is present in chronically infected woodchuck liver and woodchuck hepatocellular carcinomas which are permissive for viral replication. J Virol 70:5246\u20135254","journal-title":"J Virol"},{"key":"780_CR57","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/(SICI)1098-2744(199604)15:4<261::AID-MC3>3.0.CO;2-J","volume":"15","author":"BL Slagle","year":"1996","unstructured":"Slagle BL, Lee TH, Medina D, Finegold MJ, Butel JS (1996) Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol Carcinog 15:261\u2013269. https:\/\/doi.org\/10.1002\/(SICI)1098-2744(199604)15:4<261::AID-MC3>3.0.CO;2-J","journal-title":"Mol Carcinog"},{"key":"780_CR58","doi-asserted-by":"publisher","first-page":"12725","DOI":"10.1128\/JVI.78.23.12725-12734.2004","volume":"78","author":"MJ Bouchard","year":"2004","unstructured":"Bouchard MJ, Schneider RJ (2004) The enigmatic X gene of hepatitis B virus. J Virol 78:12725\u201312734","journal-title":"J Virol"},{"key":"780_CR59","doi-asserted-by":"publisher","first-page":"a021402","DOI":"10.1101\/cshperspect.a021402","volume":"6","author":"BL Slagle","year":"2016","unstructured":"Slagle BL, Bouchard MJ (2016) Hepatitis B virus X and regulation of viral gene expression. Cold Spring Harb Perspect Med 6:a021402. https:\/\/doi.org\/10.1101\/cshperspect.a021402","journal-title":"Cold Spring Harb Perspect Med"},{"key":"780_CR60","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3390\/v5030858","volume":"5","author":"OM Andrisani","year":"2013","unstructured":"Andrisani OM (2013) Deregulation of epigenetic mechanisms by the hepatitis B virus X protein in hepatocarcinogenesis. Viruses 5:858\u2013872. https:\/\/doi.org\/10.3390\/v5030858","journal-title":"Viruses"},{"key":"780_CR61","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/bf01703079","volume":"8","author":"CT Bock","year":"1994","unstructured":"Bock CT, Schranz P, Schroder CH, Zentgraf H (1994) Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell. Virus Genes 8:215\u2013229. https:\/\/doi.org\/10.1007\/bf01703079","journal-title":"Virus Genes"},{"key":"780_CR62","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1128\/JVI.69.6.3350-3357.1995","volume":"69","author":"JE Newbold","year":"1995","unstructured":"Newbold JE et al (1995) The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J Virol 69:3350\u20133357","journal-title":"J Virol"},{"key":"780_CR63","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1365-2893.2010.01315.x","volume":"17","author":"M Quasdorff","year":"2010","unstructured":"Quasdorff M, Protzer U (2010) Control of hepatitis B virus at the level of transcription. J Viral Hepat 17:527\u2013536, JVH1315. https:\/\/doi.org\/10.1111\/j.1365-2893.2010.01315.x","journal-title":"J Viral Hepat"},{"key":"780_CR64","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1478-3231.2010.02423.x","volume":"31","author":"I Bar-Yishay","year":"2011","unstructured":"Bar-Yishay I, Shaul Y, Shlomai A (2011) Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression. Liver Int 31:282\u2013290. https:\/\/doi.org\/10.1111\/j.1478-3231.2010.02423.x","journal-title":"Liver Int"},{"key":"780_CR65","doi-asserted-by":"publisher","unstructured":"Mohd-Ismail NK, Lim Z, Gunaratne J, Tan YJ (2019) Mapping the interactions of HBV cccDNA with host factors. Int J Mol Sci 20. https:\/\/doi.org\/10.3390\/ijms20174276","DOI":"10.3390\/ijms20174276"},{"key":"780_CR66","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1128\/JVI.68.3.2026-2030.1994","volume":"68","author":"F Zoulim","year":"1994","unstructured":"Zoulim F, Saputelli J, Seeger C (1994) Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol 68:2026\u20132030","journal-title":"J Virol"},{"key":"780_CR67","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.jhep.2011.02.015","volume":"55","author":"J Lucifora","year":"2011","unstructured":"Lucifora J, Arzberger S, Durantel D, Belloni L, Strubin M, Levrero M, Zoulim F, Hantz O, Protzer U (2011) Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection. J Hepatol 55:996\u20131003. https:\/\/doi.org\/10.1016\/j.jhep.2011.02.015","journal-title":"J Hepatol"},{"key":"780_CR68","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jhep.2015.06.023","volume":"63","author":"L Riviere","year":"2015","unstructured":"Riviere L et al (2015) HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase. J Hepatol 63:1093\u20131102. https:\/\/doi.org\/10.1016\/j.jhep.2015.06.023","journal-title":"J Hepatol"},{"key":"780_CR69","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1099\/vir.0.019224-0","volume":"91","author":"M Tsuge","year":"2010","unstructured":"Tsuge M, Hiraga N, Akiyama R, Tanaka S, Matsushita M, Mitsui F, Abe H, Kitamura S, Hatakeyama T, Kimura T, Miki D, Mori N, Imamura M, Takahashi S, Hayes CN, Chayama K (2010) HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice. J Gen Virol 91:1854\u20131864. https:\/\/doi.org\/10.1099\/vir.0.019224-0","journal-title":"J Gen Virol"},{"key":"780_CR70","doi-asserted-by":"publisher","first-page":"19975","DOI":"10.1073\/pnas.0908365106","volume":"106","author":"L Belloni","year":"2009","unstructured":"Belloni L, Pollicino T, de Nicola F, Guerrieri F, Raffa G, Fanciulli M, Raimondo G, Levrero M (2009) Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc Natl Acad Sci U S A 106:19975\u201319979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"780_CR71","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1053\/j.gastro.2006.01.001","volume":"130","author":"T Pollicino","year":"2006","unstructured":"Pollicino T, Belloni L, Raffa G, Pediconi N, Squadrito G, Raimondo G, Levrero M (2006) Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones. Gastroenterology 130:823\u2013837","journal-title":"Gastroenterology"},{"key":"780_CR72","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nature17170","volume":"531","author":"A Decorsiere","year":"2016","unstructured":"Decorsiere A et al (2016) Hepatitis B virus X protein identifies the Smc5\/6 complex as a host restriction factor. Nature 531:386\u2013389. https:\/\/doi.org\/10.1038\/nature17170","journal-title":"Nature"},{"key":"780_CR73","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/hep.28834","volume":"64","author":"B Mitra","year":"2016","unstructured":"Mitra B, Guo H (2016) Hepatitis B virus X protein crosses out Smc5\/6 complex to maintain covalently closed circular DNA transcription. Hepatology 64:2246\u20132249. https:\/\/doi.org\/10.1002\/hep.28834","journal-title":"Hepatology"},{"key":"780_CR74","doi-asserted-by":"publisher","unstructured":"Abdul F et al (2018) Smc5\/6 antagonism by HBx is an evolutionarily conserved function of hepatitis B virus infection in mammals. J Virol 92. https:\/\/doi.org\/10.1128\/JVI.00769-18","DOI":"10.1128\/JVI.00769-18"},{"key":"780_CR75","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1016\/j.celrep.2016.08.026","volume":"16","author":"CM Murphy","year":"2016","unstructured":"Murphy CM, Xu Y, Li F, Nio K, Reszka-Blanco N, Li X, Wu Y, Yu Y, Xiong Y, Su L (2016) Hepatitis B virus X protein promotes degradation of SMC5\/6 to enhance HBV replication. Cell Rep 16:2846\u20132854. https:\/\/doi.org\/10.1016\/j.celrep.2016.08.026","journal-title":"Cell Rep"},{"key":"780_CR76","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000321450","volume":"54","author":"JW Kim","year":"2011","unstructured":"Kim JW, Lee SH, Park YS, Hwang JH, Jeong SH, Kim N, Lee DH (2011) Replicative activity of hepatitis B virus is negatively associated with methylation of covalently closed circular DNA in advanced hepatitis B virus infection. Intervirology 54:316\u2013325. https:\/\/doi.org\/10.1159\/000321450","journal-title":"Intervirology"},{"key":"780_CR77","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fgene.2013.00202","volume":"4","author":"X Zhang","year":"2013","unstructured":"Zhang X, Hou J, Lu M (2013) Regulation of hepatitis B virus replication by epigenetic mechanisms and microRNAs. Front Genet 4:202. https:\/\/doi.org\/10.3389\/fgene.2013.00202","journal-title":"Front Genet"},{"key":"780_CR78","doi-asserted-by":"publisher","first-page":"e110442","DOI":"10.1371\/journal.pone.0110442","volume":"9","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Mao R, Yan R, Cai D, Zhang Y, Zhu H, Kang Y, Liu H, Wang J, Qin Y, Huang Y, Guo H, Zhang J (2014) Transcription of hepatitis B virus covalently closed circular DNA is regulated by CpG methylation during chronic infection. PLoS One 9:e110442. https:\/\/doi.org\/10.1371\/journal.pone.0110442","journal-title":"PLoS One"},{"key":"780_CR79","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1002\/jmv.21525","volume":"81","author":"Y Guo","year":"2009","unstructured":"Guo Y, Li Y, Mu S, Zhang J, Yan Z (2009) Evidence that methylation of hepatitis B virus covalently closed circular DNA in liver tissues of patients with chronic hepatitis B modulates HBV replication. J Med Virol 81:1177\u20131183. https:\/\/doi.org\/10.1002\/jmv.21525","journal-title":"J Med Virol"},{"key":"780_CR80","doi-asserted-by":"publisher","first-page":"10478","DOI":"10.1038\/srep10478","volume":"5","author":"S Jain","year":"2015","unstructured":"Jain S, Chang TT, Chen S, Boldbaatar B, Clemens A, Lin SY, Yan R, Hu CT, Guo H, Block TM, Song W, Su YH (2015) Comprehensive DNA methylation analysis of hepatitis B virus genome in infected liver tissues. Sci Rep 5:10478. https:\/\/doi.org\/10.1038\/srep10478","journal-title":"Sci Rep"},{"key":"780_CR81","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1365-2893.2007.00905.x","volume":"15","author":"P Vivekanandan","year":"2008","unstructured":"Vivekanandan P, Thomas D, Torbenson M (2008) Hepatitis B viral DNA is methylated in liver tissues. J Viral Hepat 15:103\u2013107. https:\/\/doi.org\/10.1111\/j.1365-2893.2007.00905.x","journal-title":"J Viral Hepat"},{"key":"780_CR82","doi-asserted-by":"publisher","first-page":"12450","DOI":"10.1128\/jvi.77.23.12450-12459.2003","volume":"77","author":"K Kim","year":"2003","unstructured":"Kim K, Garner-Hamrick PA, Fisher C, Lee D, Lambert PF (2003) Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J Virol 77:12450\u201312459. https:\/\/doi.org\/10.1128\/jvi.77.23.12450-12459.2003","journal-title":"J Virol"},{"key":"780_CR83","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1053\/j.gastro.2013.10.056","volume":"146","author":"Y Okamoto","year":"2014","unstructured":"Okamoto Y, Shinjo K, Shimizu Y, Sano T, Yamao K, Gao W, Fujii M, Osada H, Sekido Y, Murakami S, Tanaka Y, Joh T, Sato S, Takahashi S, Wakita T, Zhu J, Issa JP, Kondo Y (2014) Hepatitis virus infection affects DNA methylation in mice with humanized livers. Gastroenterology 146:562\u2013572. https:\/\/doi.org\/10.1053\/j.gastro.2013.10.056","journal-title":"Gastroenterology"},{"key":"780_CR84","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3892\/mmr.2015.4545","volume":"13","author":"X Fu","year":"2016","unstructured":"Fu X, Song X, Li Y, Tan D, Liu G (2016) Hepatitis B virus X protein upregulates DNA methyltransferase 3A\/3B and enhances SOCS-1CpG island methylation. Mol Med Rep 13:301\u2013308. https:\/\/doi.org\/10.3892\/mmr.2015.4545","journal-title":"Mol Med Rep"},{"key":"780_CR85","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1128\/JVI.02280-09","volume":"84","author":"P Vivekanandan","year":"2010","unstructured":"Vivekanandan P, Daniel HD, Kannangai R, Martinez-Murillo F, Torbenson M (2010) Hepatitis B virus replication induces methylation of both host and viral DNA. J Virol 84:4321\u20134329. https:\/\/doi.org\/10.1128\/JVI.02280-09","journal-title":"J Virol"},{"key":"780_CR86","doi-asserted-by":"publisher","first-page":"ra1","DOI":"10.1126\/scisignal.2001906","volume":"5","author":"D Cougot","year":"2012","unstructured":"Cougot D et al (2012) Inhibition of PP1 phosphatase activity by HBx: a mechanism for the activation of hepatitis B virus transcription. Sci Signal 5:ra1. https:\/\/doi.org\/10.1126\/scisignal.2001906","journal-title":"Sci Signal"},{"key":"780_CR87","doi-asserted-by":"publisher","unstructured":"Flecken T et al (2019) Mapping the heterogeneity of histone modifications on hepatitis B virus DNA using liver needle biopsies obtained from chronically infected patients. J Virol 93. https:\/\/doi.org\/10.1128\/JVI.02036-18","DOI":"10.1128\/JVI.02036-18"},{"key":"780_CR88","doi-asserted-by":"publisher","unstructured":"Kornyeyev D et al (2019) Spatiotemporal analysis of hepatitis B virus X protein in primary human hepatocytes. J Virol 93. https:\/\/doi.org\/10.1128\/JVI.00248-19","DOI":"10.1128\/JVI.00248-19"},{"key":"780_CR89","doi-asserted-by":"publisher","unstructured":"Allweiss L et al (2019) PS-155-HBV entry inhibition after interferon alpha treatment hinders HBV rebound in hepatocytes that became negative for all HBV markers during interferon treatment. J Hepatol 70(1):e98. https:\/\/doi.org\/10.1016\/S0618-8278(19)30173-2","DOI":"10.1016\/S0618-8278(19)30173-2"},{"key":"780_CR90","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1002\/hep.24195","volume":"53","author":"X Zhang","year":"2011","unstructured":"Zhang X, Zhang E, Ma Z, Pei R, Jiang M, Schlaak JF, Roggendorf M, Lu M (2011) Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1. Hepatology 53:1476\u20131485. https:\/\/doi.org\/10.1002\/hep.24195","journal-title":"Hepatology"},{"key":"780_CR91","doi-asserted-by":"publisher","first-page":"25389","DOI":"10.1038\/srep25389","volume":"6","author":"X Zhang","year":"2016","unstructured":"Zhang X, Liu H, Xie Z, Deng W, Wu C, Qin B, Hou J, Lu M (2016) Epigenetically regulated miR-449a enhances hepatitis B virus replication by targeting cAMP-responsive element binding protein 5 and modulating hepatocytes phenotype. Sci Rep 6:25389\u201325313. https:\/\/doi.org\/10.1038\/srep25389","journal-title":"Sci Rep"},{"key":"780_CR92","doi-asserted-by":"publisher","first-page":"7345","DOI":"10.7150\/thno.37173","volume":"9","author":"G Yang","year":"2019","unstructured":"Yang G, Feng J, Liu Y, Zhao M, Yuan Y, Yuan H, Yun H, Sun M, Bu Y, Liu L, Liu Z, Niu JQ, Yin M, Song X, Miao Z, Lin Z, Zhang X (2019) HAT1 signaling confers to assembly and epigenetic regulation of HBV cccDNA minichromosome. Theranostics 9:7345\u20137358. https:\/\/doi.org\/10.7150\/thno.37173","journal-title":"Theranostics"},{"key":"780_CR93","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jhep.2010.07.027","volume":"54","author":"MP Lambert","year":"2011","unstructured":"Lambert MP, Paliwal A, Vaissi\u00e8re T, Chemin I, Zoulim F, Tommasino M, Hainaut P, Sylla B, Scoazec JY, Tost J, Herceg Z (2011) Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake. J Hepatol 54:705\u2013715. https:\/\/doi.org\/10.1016\/j.jhep.2010.07.027","journal-title":"J Hepatol"},{"key":"780_CR94","doi-asserted-by":"publisher","unstructured":"Kuss-Duerkop SK, Westrich JA, Pyeon D (2018) DNA tumor virus regulation of host DNA methylation and its implications for immune evasion and oncogenesis. Viruses 10. https:\/\/doi.org\/10.3390\/v10020082","DOI":"10.3390\/v10020082"},{"key":"780_CR95","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/cdd.2015.129","volume":"23","author":"K Yuan","year":"2016","unstructured":"Yuan K, Lei Y, Chen HN, Chen Y, Zhang T, Li K, Xie N, Wang K, Feng X, Pu Q, Yang W, Wu M, Xiang R, Nice EC, Wei Y, Huang C (2016) HBV-induced ROS accumulation promotes hepatocarcinogenesis through Snail-mediated epigenetic silencing of SOCS3. Cell Death Differ 23:616\u2013627. https:\/\/doi.org\/10.1038\/cdd.2015.129","journal-title":"Cell Death Differ"},{"key":"780_CR96","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.3892\/or.2017.5518","volume":"37","author":"Z Zhao","year":"2017","unstructured":"Zhao Z, Hu Y, Shen X, Lao Y, Zhang L, Qiu X, Hu J, Gong P, Cui H, Lu S, Zheng Y, Zhou M, Fan H (2017) HBx represses RIZ1 expression by DNA methyltransferase 1 involvement in decreased miR-152 in hepatocellular carcinoma. Oncol Rep 37:2811\u20132818. https:\/\/doi.org\/10.3892\/or.2017.5518","journal-title":"Oncol Rep"},{"key":"780_CR97","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1053\/j.gastro.2007.01.034","volume":"132","author":"IY Park","year":"2007","unstructured":"Park IY, Sohn BH, Yu E, Suh DJ, Chung YH, Lee JH, Surzycki SJ, Lee YI (2007) Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology 132:1476\u20131494","journal-title":"Gastroenterology"},{"key":"780_CR98","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12864-017-3561-5","volume":"18","author":"F Guerrieri","year":"2017","unstructured":"Guerrieri F, Belloni L, D\u2019Andrea D, Pediconi N, le Pera L, Testoni B, Scisciani C, Floriot O, Zoulim F, Tramontano A, Levrero M (2017) Genome-wide identification of direct HBx genomic targets. BMC Genomics 18:184. https:\/\/doi.org\/10.1186\/s12864-017-3561-5","journal-title":"BMC Genomics"},{"key":"780_CR99","doi-asserted-by":"publisher","first-page":"e0169648","DOI":"10.1371\/journal.pone.0169648","volume":"12","author":"C Niu","year":"2017","unstructured":"Niu C, Livingston CM, Li L, Beran RK, Daffis S, Ramakrishnan D, Burdette D, Peiser L, Salas E, Ramos H, Yu M, Cheng G, Strubin M, Delaney WEIV, Fletcher SP (2017) The Smc5\/6 complex restricts HBV when localized to ND10 without inducing an innate immune response and is counteracted by the HBV X protein shortly after infection. PLoS One 12:e0169648. https:\/\/doi.org\/10.1371\/journal.pone.0169648","journal-title":"PLoS One"},{"key":"780_CR100","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.15252\/embj.201591829","volume":"34","author":"A Jacome","year":"2015","unstructured":"Jacome A et al (2015) NSMCE2 suppresses cancer and aging in mice independently of its SUMO ligase activity. EMBO J 34:2604\u20132619. https:\/\/doi.org\/10.15252\/embj.201591829","journal-title":"EMBO J"},{"key":"780_CR101","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1186\/1471-2164-13-563","volume":"13","author":"Y Guo","year":"2012","unstructured":"Guo Y, Kang W, Lei X, Li Y, Xiang A, Liu Y, Zhao J, Zhang J, Yan Z (2012) Hepatitis B viral core protein disrupts human host gene expression by binding to promoter regions. BMC Genomics 13:563. https:\/\/doi.org\/10.1186\/1471-2164-13-563","journal-title":"BMC Genomics"},{"key":"780_CR102","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1053\/j.gastro.2006.08.026","volume":"132","author":"K Panzitt","year":"2007","unstructured":"Panzitt K et al (2007) Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 132:330\u2013342. https:\/\/doi.org\/10.1053\/j.gastro.2006.08.026","journal-title":"Gastroenterology"},{"key":"780_CR103","doi-asserted-by":"publisher","unstructured":"Cornberg M, Suk-Fong Lok A, Terrault NA, Zoulim F, Berg, E.-A. H. T. E. C. F (2019) Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference. J Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2019.11.003","DOI":"10.1016\/j.jhep.2019.11.003"},{"key":"780_CR104","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s11912-011-0186-8","volume":"13","author":"JC Ramos","year":"2011","unstructured":"Ramos JC, Lossos IS (2011) Newly emerging therapies targeting viral-related lymphomas. Curr Oncol Rep 13:416\u2013426. https:\/\/doi.org\/10.1007\/s11912-011-0186-8","journal-title":"Curr Oncol Rep"},{"key":"780_CR105","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.7150\/ijms.26125","volume":"15","author":"HB Yu","year":"2018","unstructured":"Yu HB, Jiang H, Cheng ST, Hu ZW, Ren JH, Chen J (2018) AGK2, a SIRT2 inhibitor, inhibits hepatitis B virus replication in vitro and in vivo. Int J Med Sci 15:1356\u20131364. https:\/\/doi.org\/10.7150\/ijms.26125","journal-title":"Int J Med Sci"},{"key":"780_CR106","doi-asserted-by":"publisher","first-page":"s690","DOI":"10.1016\/S0168-8278(17)31855-X","volume":"66","author":"S Gilmore","year":"2017","unstructured":"Gilmore S, T D, Dick R, Appleby T, Birkus G, Willkom M, Delaney WE, Notte GT, Feierbach B (2017) SAT-160 antiviral activityof GS-5801, a liver-targeted prodrug of a lysine demethylase 5 inhibitor, in a hepatitis B virus primary human hepatocyte infection model. J Hepatol 66:s690\u2013s691","journal-title":"J Hepatol"},{"key":"780_CR107","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/hep.29133","volume":"66","author":"W Zhang","year":"2017","unstructured":"Zhang W, Chen J, Wu M, Zhang X, Zhang M, Yue L, Li Y, Liu J, Li B, Shen F, Wang Y, Bai L, Protzer U, Levrero M, Yuan Z (2017) PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation. Hepatology 66:398\u2013415. https:\/\/doi.org\/10.1002\/hep.29133","journal-title":"Hepatology"},{"key":"780_CR108","doi-asserted-by":"publisher","first-page":"587","DOI":"10.18632\/oncotarget.1782","volume":"5","author":"H Li","year":"2014","unstructured":"Li H et al (2014) Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers. Oncotarget 5:587\u2013598. https:\/\/doi.org\/10.18632\/oncotarget.1782","journal-title":"Oncotarget"},{"key":"780_CR109","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1053\/j.gastro.2015.09.026","volume":"150","author":"Y Xia","year":"2016","unstructured":"Xia Y, Stadler D, Lucifora J, Reisinger F, Webb D, H\u00f6sel M, Michler T, Wisskirchen K, Cheng X, Zhang K, Chou WM, Wettengel JM, Malo A, Bohne F, Hoffmann D, Eyer F, Thimme R, Falk CS, Thasler WE, Heikenwalder M, Protzer U (2016) Interferon-gamma and tumor necrosis factor-alpha produced by T cells reduce the HBV persistence form, cccDNA, Without Cytolysis. Gastroenterology 150:194\u2013205. https:\/\/doi.org\/10.1053\/j.gastro.2015.09.026","journal-title":"Gastroenterology"}],"container-title":["Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-020-00780-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00281-020-00780-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-020-00780-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:19:42Z","timestamp":1615940382000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00281-020-00780-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":109,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["780"],"URL":"https:\/\/doi.org\/10.1007\/s00281-020-00780-6","relation":{},"ISSN":["1863-2297","1863-2300"],"issn-type":[{"value":"1863-2297","type":"print"},{"value":"1863-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,17]]},"assertion":[{"value":"28 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}